Belgian CDMO Acquired by Catalent

Belgian CDMO Acquired by Catalent

Catalent, Inc. (NYSE: CTLT) announced a $315 million deal for MaSTherCell Global, a technology-focused cell and gene therapy contract development and manufacturing organization based in Gosselies, Belgium. It is backed by Great Point Partners, SFPI-FPIM (the Belgian Federal Holdings and Investment Company) and Orgenesis Inc. (NASDAQ: ORGS). This is the Somerset, New Jersey-based CRO’s fifth deal since 2014, all of them for domestic targets. Its most recent one was announced in April 2019, for Baltimore-based Paragon Bioservices, Inc., a contract research organization, for $1.2 billion. Founded in 2011, MaSTherCell has a 25,000-square-foot facility in Gosselies, providing clinical... Read More »